Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Assets: 2020-2025

Historic Return on Assets for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to -0.05%.

  • Mirum Pharmaceuticals' Return on Assets rose 10.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.13% for FY2024, which is 19.00% up from last year.
  • Mirum Pharmaceuticals' Return on Assets amounted to -0.05% in Q3 2025, which was up 33.71% from -0.08% recorded in Q2 2025.
  • Mirum Pharmaceuticals' Return on Assets' 5-year high stood at -0.05% during Q3 2025, with a 5-year trough of -0.74% in Q3 2021.
  • Over the past 3 years, Mirum Pharmaceuticals' median Return on Assets value was -0.17% (recorded in 2024), while the average stood at -0.21%.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Return on Assets surged by 61bps in 2022, and later decreased by 27bps in 2023.
  • Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Return on Assets stood at -0.32% in 2021, then decreased by 6bps to -0.38% in 2022, then climbed by 13bps to -0.25% in 2023, then climbed by 12bps to -0.13% in 2024, then rose by 10bps to -0.05% in 2025.
  • Its Return on Assets stands at -0.05% for Q3 2025, versus -0.08% for Q2 2025 and -0.11% for Q1 2025.